Therapeutic Antibody Engineering: Past, Present and Future

Listicle

Published: September 28, 2021

Mariana Gil, PhD

Therapeutic Antibody Engineering: Past, Present and Future content piece image

Credit: iStock

Therapeutic antibodies (Abs) represent the predominant class of novel drugs developed in recent years which work by binding to specific (Ags) to activate or inhibit biological processes that are implicated in a specific disease.

Download this listicle to learn more about:

The types of therapeutic antibodies and their applications
Antibody engineering
Current challenges and future prospects

Meet the Author

Mariana Gil, PhD

Custom Content Manager

Mariana Gil holds a PhD in biological sciences from the Free University of Berlin, Germany. She moved into science communication in 2021 after almost two decades in academia.